A Prospective Randomized Single-Blind Comparison of Ureteral Stents Composed of Firm and Soft Polymer

Joshi, H.B.; Chitale, Sudhanshu; Nagarajan, M.; Irving, Stuart; Browning, Anthony J.; Biyani, Chandra Shekhar; Burgess, Neil

doi:10.1097/01.ju.0000181815.63998.5f

Cited by 73 publications

(44 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Inclusion criteria were: (i) study assesses measures to treat or prevent SRS; (ii) standard indications for ureteral stenting; and (iii) use of USSQ, and reporting of at least urinary symptoms score and body pain score. However, aside from eight trials assessing drug treatment, which were already the subject of the metaanalyses described above, 12,14 just two further studies 25,26 met the inclusion criteria. Although many of the trials using the USSQ did not provide the actual numbers for USSQ total score and subscores, the remaining studies applied a multiplicity of tools to assess stent-related morbidity (i.e.…”

Section: Discussionmentioning

confidence: 99%

“…25 According to sample size calculation, 116 patients were analyzed using the USSQ as the primary outcome measure at 1 and 4 weeks after stent insertion. The authors found no significant differences regarding urinary symptoms, pain, general health and work performance at both times, and concluded that stent composition alone does not seem to influence patient comfort and overall ureteral stent experience.…”

Section: Stent Materials and Designmentioning

confidence: 99%

See 1 more Smart Citation

Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review

et al. 2017

View full text Add to dashboard Cite

Temporary drainage of the upper urinary tract by internal ureteral stents is a routine procedure in endourology. However, it is associated with a clear side-effect profile. Our aim was to evaluate prevention and treatment options of stent-related symptoms. We carried out a systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines using MEDLINE and SCOPUS, and identified 107 appropriate records. A high number of these studies showed clear methodological limitations. Available data clearly support the use of a 1 -blockers in patients suffering from stent-related symptoms. It seems that antimuscarinic monotherapy or combination with a 1 -blockers might also play an important role, whereas the use of classical analgesics in the treatment of stent-related symptoms has not been assessed systematically within clinical trials so far. Improvements in stent design and material seem to have the potential to reduce stent-related symptoms. However, so far there is no type of stent with outstanding characteristics and clear evidence suggesting fundamental advantages compared with a standard double pigtail stent. Although stent diameter does not seem to influence patients' comfort, it seems to be beneficial to choose a proper stent-length. Coated and drug-eluting stents, as well as intravesical drug application, seem to be promising concepts to prevent stent-related symptoms, but still have to be considered as experimental approaches. Furthermore, thorough patient education has the potential to reduce the morbidity associated with ureteral stenting. Further research in the field seems to be mandatory.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Stent Materials and Designmentioning

confidence: 99%

Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Stents have been associated with increased morbidity causing infection, (Riedl, Plas et al 1999) encrustation, (Paick, Park et al 2003) hematuria, (Damiano, Oliva et al 2002;Joshi, Newns et al 2003;Joshi, Chitale et al 2005) and discomfort (Joshi, Stainthorpe et al 2001;Joshi, Okeke et al 2002). The Ureteral Stent Symptom Questionnaire (USSQ) looks at different facets of life including sexual function which has been shown to be negatively affected by the presence of a stent (Sighinolfi, Micali et al 2007).…”

Section: Problems Arising From Stentsmentioning

confidence: 99%

Biomaterials in Urology - Beyond Drug Eluting and Degradable - A Rational Approach to Ureteral Stent Design

Lange¹,

Elwood²,

Chew³

2011

Biomaterials - Physics and Chemistry

View full text Add to dashboard Cite

“…Urinary stents contain various materials, and are available with different sizes, coatings and shapes to avoid unpleasant urinary symptoms and discomfort [8][9][10] . Joshi et al developed the ureteral stent symptom questionnaire (USSQ) to assess ureteral stent discomfort.…”

Section: Introductionmentioning

confidence: 99%

“…Joshi et al developed the ureteral stent symptom questionnaire (USSQ) to assess ureteral stent discomfort. The USSQ is a self-administered, multidimensional instrument that has six sections that address urinary symptoms, body pain, general health, work performance, sexual matters and additional problems [9,11] . Studies of stent-related symptoms using the USSQ reveal that stent length is the most important factor [12,13] .…”

Section: Introductionmentioning

confidence: 99%

Choosing an Appropriate Length of Loop Type Ureteral Stent Using Direct Ureteral Length Measurement

Kawahara¹,

Ito

Terao

et al. 2011

Urol Int

View full text Add to dashboard Cite

Purpose: The ureteral stent is now a fundamental part of many urological procedures. To decrease ureteral stent-related symptoms, loop type ureteral stent was developed. However the most important factor to decrease urinary symptoms is choosing the optimal length of a ureteral stent. We investigated the relationship between the actual ureteral length and the loop type ureteral stent position. Materials and Methods: A total of 226 loop type polyurethane ureteral stents (156 patients) were inserted with four options for stent length (20, 22, 24 and 26 cm). The ureteral length was measured using a ruled 5-Fr ureteral catheter. The appropriateness of stent position was defined into three groups based on kidney-ureter-bladder films. Results: Nine stents (3.9%) migrated, 171 stents (75.7%) were in the appropriate position and 46 stents (19.5%) were overlong. The rate of migration rate and overlong stents closely correlated with the ureteral length when the proximal end of the stent was in the renal pelvis. Conclusions: It is appropriate to choose a loop type ureteral stent that is the same or 1 cm less than the length of the ureter when the proximal end of the stent will be in the renal pelvis.

show abstract

A Prospective Randomized Single-Blind Comparison of Ureteral Stents Composed of Firm and Soft Polymer

Abstract: This randomized study showed no difference in the impact on patient quality of life between ureteral stents composed of firm or soft polymer.

Cited by 73 publications

References 10 publications

Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review

Prevention and treatment of symptoms associated with indwelling ureteral stents: A systematic review

Biomaterials in Urology - Beyond Drug Eluting and Degradable - A Rational Approach to Ureteral Stent Design

Choosing an Appropriate Length of Loop Type Ureteral Stent Using Direct Ureteral Length Measurement

Contact Info

Product

Resources

About